Ann E Berman
Director at Loews Corp (L)
Ann E Berman has filed 42 insider reports with the SEC since March 2021, as director at Loews Corp (L), director at Immuneering Corp (IMRX) and director at Cantel Medical Corp (CMD). In the last 12 months Ann E Berman sold $368K of stock on the open market. The latest filing, on March 31, 2026, reports grant or award at Loews Corp (L).
- Filings
- 42
- Companies
- 3
- Bought on market
- $162K
- Sold on market
- $1.92M
Companies where Ann E Berman is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 5,233 | $1.47M | $110.20 | Mar 31, 2026 | |||
| Director | 67,465 | $162K | $2.53 | $3.46+37% | Sep 23, 2025 | ||
| Director | 0 | $453K | Jun 2, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Mar 31, 2026LSEC Form 4 filed by Berman Ann EForm 4Grant or award
- Feb 10, 2026-$212KLDirector Berman Ann E sold $211,728 worth of shares (1,922 units at $110.16), decreasing direct ownership by 28% to 4,998 unitsForm 4Open-market sale
- Dec 31, 2025LDirector Berman Ann E was granted 234 shares, increasing direct ownership by 3% to 6,920 unitsForm 4Grant or award
- Dec 1, 2025-$156KLDirector Berman Ann E sold $156,096 worth of shares (1,444 units at $108.10), exercised 2,250 shares at a strike of $38.67 and returned $87,153 worth of shares to the company (806 units at $108.13)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 30, 2025LDirector Berman Ann E was granted 251 shares, increasing direct ownership by 4% to 6,686 unitsForm 4Grant or award
- Sep 23, 2025~$136KIMRXAnn E Berman plans to sell 14,000 shares (~$136K)Form 144Planned sale
- Sep 2, 2025-$137KLDirector Berman Ann E sold $137,465 worth of shares (1,422 units at $96.67), exercised 2,250 shares at a strike of $35.52 and returned $80,068 worth of shares to the company (828 units at $96.70)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 30, 2025LDirector Berman Ann E was granted 149 shares, increasing direct ownership by 2% to 6,435 unitsForm 4Grant or award
- Jun 13, 2025IMRXSEC Form 4 filed by Director Berman Ann EForm 4Grant or award
- Jun 2, 2025-$113KLDirector Berman Ann E exercised 2,250 shares at a strike of $38.46, returned $86,699 worth of shares to the company (977 units at $88.74) and sold $113,068 worth of shares (1,273 units at $88.82)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 14, 2025LDirector Berman Ann E converted options into 1,288 shares, increasing direct ownership by 26% to 6,286 unitsForm 4Exercise or conversion of a derivative
- Mar 3, 2025-$104KLDirector Berman Ann E exercised 2,250 shares at a strike of $40.61, returned $91,495 worth of shares to the company (1,053 units at $86.89) and sold $104,019 worth of shares (1,197 units at $86.90)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 3, 2025~$104KLAnn E Berman plans to sell 1,197 shares (~$104K)Form 144Planned sale10b5-1 plan
- Jan 1, 2025IMRXSEC Form 4 filed by Director Berman Ann EForm 4Grant or award
- Dec 2, 2024-$99.1KLDirector Berman Ann E exercised 2,250 shares at a strike of $42.52, returned $95,827 worth of shares to the company (1,104 units at $86.80) and sold $99,106 worth of shares (1,146 units at $86.48)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 3, 2024-$88.5KLDirector Berman Ann E exercised 2,250 shares at a strike of $41.98, returned $94,622 worth of shares to the company (1,163 units at $81.36) and sold $88,460 worth of shares (1,087 units at $81.38)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 12, 2024IMRXSEC Form 4 filed by Director Berman Ann EForm 4Grant or award
- Jun 3, 2024-$73KLBerman Ann E exercised 2,250 shares at a strike of $43.83, returned $98,571 worth of shares to the company (1,287 units at $76.59) and sold $72,995 worth of shares (963 units at $75.80)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 14, 2024LSEC Form 4 filed by Berman Ann EForm 4Grant or award
- May 9, 2024LBerman Ann E converted options into 1,706 shares, increasing direct ownership by 52% to 4,998 unitsForm 4Exercise or conversion of a derivative
- Mar 18, 2024+$123KIMRXBerman Ann E bought $123,436 worth of shares (57,965 units at $2.13), increasing direct ownership by 610% to 67,465 unitsForm 4Open-market purchase
- Mar 1, 2024-$71.3KLBerman Ann E exercised 2,250 shares at a strike of $43.37, returned $97,516 worth of shares to the company (1,299 units at $75.07) and sold $71,344 worth of shares (951 units at $75.02)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 1, 2023-$50.2KLBerman Ann E exercised 2,250 shares at a strike of $47.84, returned $107,573 worth of shares to the company (1,535 units at $70.08) and sold $50,164 worth of shares (715 units at $70.16)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 1, 2023-$35.1KLSEC Form 4: Berman Ann E exercised 2,250 shares at a strike of $46.99, returned $105,698 worth of shares to the company (1,689 units at $62.58) and sold $35,096 worth of shares (561 units at $62.56)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 14, 2023IMRXSEC Form 4 filed by Berman Ann EForm 4Grant or award
- Jun 1, 2023-$26.7KLSEC Form 4 filed by Berman Ann EForm 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 10, 2023LSEC Form 4 filed by Berman Ann EForm 4Grant or awardExercise or conversion of a derivative
- Mar 1, 2023-$38.1KLSEC Form 4: Berman Ann E exercised 2,250 shares at a strike of $43.89, returned $98,719 worth of shares to the company (1,625 units at $60.75) and sold $38,112 worth of shares (625 units at $60.98)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale
- Dec 1, 2022-$40.4KLSEC Form 4: Berman Ann E exercised 2,250 shares at a strike of $40.47, returned $91,040 worth of shares to the company (1,552 units at $58.66) and sold $40,414 worth of shares (698 units at $57.90)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale
- Sep 1, 2022-$31.4KLSEC Form 4: Berman Ann E exercised 2,250 shares at a strike of $41.14, returned $92,558 worth of shares to the company (1,678 units at $55.16) and sold $31,403 worth of shares (572 units at $54.90)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale
- Jun 21, 2022IMRXSEC Form 4 filed by Berman Ann EForm 4Grant or award
- Jun 1, 2022-$57KLSEC Form 4: Berman Ann E exercised 2,250 shares at a strike of $39.80, returned $89,511 worth of shares to the company (1,367 units at $65.48) and sold $56,998 worth of shares (883 units at $64.55)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale
- May 11, 2022LSEC Form 4: Berman Ann E converted options into 1,725 sharesForm 4Grant or awardExercise or conversion of a derivative
- Mar 15, 2022+$38.4KIMRXSEC Form 4: Berman Ann E bought $38,400 worth of shares (6,000 units at $6.40), increasing direct ownership by 171% to 9,500 unitsForm 4Open-market purchase
- Mar 1, 2022-$47.7KLSEC Form 4: Berman Ann E exercised 2,250 shares at a strike of $39.41, returned $88,662 worth of shares to the company (1,453 units at $61.02) and sold $47,732 worth of shares (797 units at $59.89)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale
- Dec 1, 2021-$25.1KLSEC Form 4: Berman Ann E returned $56,662 worth of shares to the company (1,041 units at $54.43), sold $25,112 worth of shares (459 units at $54.71) and exercised 1,500 shares at a strike of $37.78Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale
- Sep 1, 2021-$31.2KLSEC Form 4: Berman Ann E exercised 1,500 units of Common Stock at a strike of $35.04, returned $52,556 worth of Common Stock to the company (939 units at $55.97) and sold $31,203 worth of Common Stock (561 units at $55.62)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale
- Jun 2, 2021CMDSEC Form 4: BERMAN ANN E returned $335,174 worth of Common Stock to the company (4,159 units at $80.59) , decreasing direct ownership by 100% to 0 unitsForm 4Sale back to the company
- Jun 1, 2021-$25.2KLSEC Form 4: BERMAN ANN E exercised 1,500 units of Common Stock at a strike of $42.02, returned $63,018 worth of Common Stock to the company (1,071 units at $58.84) and sold $25,174 worth of Common Stock (429 units at $58.68)Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale
- May 11, 2021LSEC Form 4 filed by BERMAN ANN EForm 4Grant or award
- Apr 5, 2021-$453KCMDSEC Form 4: E Ann Berman sold $453,255 worth of Common Stock (5,500 units at $82.41), decreasing direct ownership by 57% to 4,159 unitsForm 4Open-market sale
- Mar 1, 2021-$8,391LSEC Form 4: E Ann Berman disposed to the issuer $64,665 worth of Common Stock (1,330 units at $48.62), sold $8,391 worth of Common Stock (170 units at $49.36) and exercised 1,500 units of Common Stock at a strike of $43.14Form 4Sale back to the companyExercise or conversion of a derivativeOpen-market sale
Compare Ann E Berman with
- Ann E Berman vs Charles M Diker2 shared
- Ann E Berman vs Andrew Gengos1 shared
- Ann E Berman vs Mark S Schwartz1 shared
- Ann E Berman vs James S Tisch1 shared
- Ann E Berman vs Grant C. Bogle1 shared
- Ann E Berman vs Jennifer VanBelle1 shared
Other insiders at the same companies
- Andrew GengosIMRX
- Mark S SchwartzL
- James S TischL
- Grant C. BogleIMRX
- Jennifer VanBelleL
- Dino RobustoL
- Susan PetersL
- Jonathan C LockerL
- Walter L HarrisL
- Paul J FribourgL
- Charles D DavidsonL
- Andrew H TischL
- Charles M DikerL
- Benjamin J. ZeskindIMRX
- Brett Matthew HallIMRX
- Thomas J. SchallIMRX
Questions about Ann E Berman
- What is Ann E Berman's role at Loews Corp?
- Ann E Berman reports to the SEC as director at Loews Corp (L), according to the latest filing on March 31, 2026. Ann E Berman has also filed as director at Immuneering Corp (IMRX) and director at Cantel Medical Corp (CMD).
- How many shares does Ann E Berman own?
- After the latest filing that states it, Ann E Berman directly owned 5,233 shares of Loews Corp (L) and 67,465 shares of Immuneering Corp (IMRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Ann E Berman bought or sold stock recently?
- The most recent open-market purchase was on March 18, 2024: bought 57,965 shares of Immuneering Corp (IMRX) for $123K at an average of $2.13. The most recent open-market sale was on February 10, 2026: sold 1,922 shares of Loews Corp (L) for $212K at an average of $110.16.
- How do I get alerts when Ann E Berman files?
- Follow Ann E Berman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Ann E Berman (SEC CIK 0001349408). Totals count each trade once, skipping amendments whose original is on file, from Mar 2, 2021 on. View on SEC EDGAR